OQROGet OQRO Pro
Insider trade

Starling Oncology (STLN)Director sold ~$2.11M

Growth I L.p. M33, Director at Starling Oncology, sold ~$2.11M of Starling Oncology shares.

~$2.11M
Approx. value · 682K sh @ $3.09
591K
Holds after · shares reported
Traded
Sep 4, 2025
Filed
Sep 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 19, 2025InsiderDirector sold ~$82K of STLN shares in the open market
  2. Sep 4, 2025 · this disclosureInsiderDirector sold ~$2.11M of STLN shares in the open market

What came next

  1. Sep 4, 2025InsiderDirector sold ~$18.6M of STLN shares in the open market
  2. Nov 13, 2025Company filing · Form 8-K · ResultsReported its results
  3. Nov 26, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On November 26, 2025, Gabriel Ling resigned from the Board of Directors of The Oncology Institute, Inc. (the “Company”), effective on December 1, 2025. Mr. Ling’s resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Starling Oncology

OQRO holds no insider, Congress, fund or contract record for Starling Oncology dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STLN page.

Other recent filings by Growth I L.p. M33, Director

The full history of Growth I L.p. M33, Director is on the profile page.

How this filing works

Other disclosures at Starling Oncology

Everything OQRO holds on this company is on its STLN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data